Top Markets
Coin of the day
Tectonic Therapeutic, Inc. Tectonic Therapeutic, Inc.

Tectonic Therapeutic, Inc.

TECX
Rang in Aktien #11671
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm... Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.
Aktienkurs
$35.63
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$672.28M
Veränderung (1 Tag)
-2.92%
Veränderung (1 Jahr)
39.50%
Land
US
Handel Tectonic Therapeutic, Inc. (TECX)

Kategorie

Kursverlauf für Tectonic Therapeutic, Inc. (TECX)
Höchster Schlusskurs: $35.01 am 2026-08-01

Niedrigster Schlusskurs: $360.74 am 2018-06-01
Kursverlauf der Aktie von Tectonic Therapeutic, Inc. von 2018 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 24.56%
2025 -58.38%
2024 195.42%
2023 72.46%
2022 -79.14%
2021 -73.01%
2020 -28.18%
2019 -9.11%
2018 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH